Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

TransMedics (TMDX) Tax Provisions (2018 - 2026)

TransMedics has reported Tax Provisions over the past 8 years, most recently at -$103.3 million for Q4 2025.

  • For Q4 2025, Tax Provisions fell 122876.19% year-over-year to -$103.3 million; the TTM value through Dec 2025 reached -$102.3 million, down 102394.0%, while the annual FY2025 figure was $56000.0, 44.0% down from the prior year.
  • Tax Provisions for Q4 2025 was -$103.3 million at TransMedics, down from -$1.3 million in the prior quarter.
  • Over five years, Tax Provisions peaked at $1.5 million in Q4 2023 and troughed at -$103.3 million in Q4 2025.
  • A 5-year average of -$5.1 million and a median of $14000.0 in 2021 define the central range for Tax Provisions.
  • Biggest five-year swings in Tax Provisions: soared 7789.47% in 2023 and later plummeted 122876.19% in 2025.
  • Year by year, Tax Provisions stood at $17000.0 in 2021, then grew by 11.76% to $19000.0 in 2022, then soared by 7789.47% to $1.5 million in 2023, then plummeted by 105.6% to -$84000.0 in 2024, then plummeted by 122876.19% to -$103.3 million in 2025.
  • Business Quant data shows Tax Provisions for TMDX at -$103.3 million in Q4 2025, -$1.3 million in Q3 2025, and $1.3 million in Q2 2025.